News | Atrial Fibrillation | January 02, 2018

Heart Rhythm Society Partners With WebMD Education to Increase Atrial Fibrillation Awareness

New collaboration results in launch of online tool designed to educate patients and caregivers about the risks associated with AFib

Heart Rhythm Society Partners With WebMD Education to Increase Atrial Fibrillation Awareness

January 2, 2018 — The Heart Rhythm Society (HRS), in partnership with WebMD Education, announced in December the launch of a free, online educational tool called “How to Reduce Your Risk of Stroke Due to AFib.” The new tool is part of a larger series of educational activities hosted by WebMD Education to help patients, caregivers and those who may be at risk to learn more about various medical conditions. The atrial fibrillation (AFib)-focused tool is an easy-to-use, interactive activity delivering important information straight into the hands of the user. This is the first collaboration between HRS and WebMD Education.

Atrial fibrillation (AFib), the most common heart arrhythmia, affects more than 33 million people worldwide and has been known to increase a person’s risk of stroke by 500 percent and even death.[1][2] In the United States, more than 2.5 million adults are living with AFib, and it accounts for approximately one-third of hospitalizations for cardiac rhythm disturbances. AFib occurs when the upper chambers of the heart (the atria) fibrillate, or “quiver,” which causes a rapid, irregular heart rhythm. The normal heart rate for an adult is between 60 and 100 beats per minute. When the heart experiences AFib, the atria can beat over 300 times every minute.

The new online tool, which can be accessed on WebMD Education and via its sister site, Medscape, presents physician-reviewed, expert content about the signs and symptoms of AFib.  Upon completing the activity, users are more aware of AFib and the risks associated with the condition. Specifically, the tool covers the following topic areas:

  • Definition and Types of AFib;
  • Symptoms and Risks;
  • How AFib is Diagnosed;
  • Understanding and Preventing Stroke;
  • Goals and Types of Treatment; and
  • What to Ask Your Doctor       

“In a day in age where information, correct and incorrect, is available at your fingertips, it is more important than ever to arm patients with accurate and helpful information about their health. With our physician-led expertise in electrophysiology and WebMD’s extensive digital footprint, this interactive tool provides patients and caregivers with information that will allow for more open and informed conversations with physicians,” said Lynda E. Rosenfeld, M.D., FHRS, professor of medicine and pediatrics at the Yale School of Medicine. “HRS has an ongoing commitment to help educate the public about life-threatening arrhythmias, and what better partner than WebMD to share in this mission to help save lives.”

In 2015, a survey of 240 patient and caregiver respondents conducted by HRS gathered insights about common practices related to searching for heart arrhythmia information. Survey findings demonstrated the importance of readily available tools — indicating physicians, internet searches and internet consumer medical sites such as WebMD are top resources for learning about heart arrhythmia. Additionally, the survey revealed that 98 percent of respondents view WebMD as their main source of health information, and more than 60 percent of respondents have used and would use WebMD again for information on heart arrhythmias.

The new online activity available on WedMD Education is supported in part by Boehringer Ingelheim Pharmaceuticals Inc., Bristol-Myers Squibb & Pfizer Alliance, Janssen Pharmaceuticals and Medtronic Inc.

For more information: www.myafib.org

Related Content

Medtronic's DiamondTemp Ablation (DTA) system is FDA cleared to treat patients with recurrent, symptomatic paroxysmal atrial fibrillation (AF) and who have been unresponsive to drug therapy. The DiamondTemp system is the first FDA-approved, temperature-controlled, irrigated radiofrequency (RF) ablation system with diamonds currently available to deliver ablations.

Medtronic's DiamondTemp Ablation (DTA) system is FDA cleared to treat patients with recurrent, symptomatic paroxysmal atrial fibrillation (AF) and who have been unresponsive to drug therapy. The DiamondTemp system is the first FDA-approved, temperature-controlled, irrigated radiofrequency (RF) ablation system with diamonds currently available to deliver ablations.

News | Atrial Fibrillation | January 29, 2021
January 29, 2021 — The U.S.
Patients with atrial fibrillation are at far greater risk of a catastrophic COVID outcomes, so steps should be taken to reduce AFib risks in addition to precautions against COVID like making, hand washing and social distancing. Images include an electromap from an AF ablation procedure and a COVID-19 from the CDC. 

Patients with atrial fibrillation are at far greater risk of a catastrophic COVID outcomes, so steps should be taken to reduce AFib risks in addition to precautions against COVID like making, hand washing and social distancing. Images include an electromap from an AF ablation procedure and a COVID-19 from the CDC. 

Feature | Atrial Fibrillation | January 27, 2021 | By John D. Day, M.D., T. Jared Bunch, M.D., and Matthew D. LaPlante
In our most challenging and distressing days, it is nice to think about a post-COVID-19 world. 
ECG with paroxysm correct form of atrial flutter. Getty Images

ECG with paroxysm correct form of atrial flutter. Getty Images

News | Atrial Fibrillation | December 23, 2020
December 23, 2020 — The American College of Cardiology (ACC) and the American Heart Association (AHA) has made two up
The three-year clinical outcomes of the mHealth Screening to Prevent Strokes (mSToPS) study evaluated the detection of silent, or previously undiagnosed, atrial fibrillation (AF) in moderate-risk individuals using the FDA-cleared Zio by iRhythm ambulatory monitoring patch. The results support the clinical value of early screening and targeted detection in moderate-risk populations. #AHA #AHA20 #AHA2020

The three-year clinical outcomes of the mHealth Screening to Prevent Strokes (mSToPS) study evaluated the detection of silent, or previously undiagnosed, atrial fibrillation (AF) in moderate-risk individuals using the FDA-cleared Zio by iRhythm ambulatory monitoring patch. The results support the clinical value of early screening and targeted detection in moderate-risk populations.

News | Atrial Fibrillation | November 16, 2020
November 16, 2020 — The three-year clinical outcomes of the mHealth Screening to Prevent Strokes (mSToPS) study evalu
The Medtronic SEEQ mobile cardiac telemetry system, pictured here, and the Icentia CardioSTAT cardiac rhythm monitoring device both found in reased rates of post-operative atrial fibrillation in the SEARCH-AF trial presented at the American Heart Association annual meeting. #AHA #AHA20 #AHA2020

The Medtronic SEEQ mobile cardiac telemetry system, pictured here, and the Icentia CardioSTAT cardiac rhythm monitoring device both found in reased rates of post-operative atrial fibrillation in the SEARCH-AF trial presented at the American Heart Association annual meeting.

News | Atrial Fibrillation | November 16, 2020
November 16, 2020 — Atrial fibrill...
The Medtronic Arctic Front cryoballoon balloon was used a a front-line treatment of AF in the EARLY-AF trial. It was found to be better than anti-arrhythmic drugs in preventing the recurrence of abnormal heart rhythm (atrial tachyarrhythmia, atrial fibrillation), and improve patient well-being.  #AHA #AHA2020 #AHA20

The Medtronic Arctic Front cryoballoon balloon was used a a front-line treatment of AF in the EARLY-AF trial. It was found to be better than anti-arrhythmic drugs in preventing the recurrence of abnormal heart rhythm (atrial tachyarrhythmia, atrial fibrillation), and improve patient well-being.  

News | Atrial Fibrillation | November 16, 2020
November 16, 2020 – Doctors from the Mo...

The study used cadaver hearts that were images with contrast enhanced MRI and the images used to create a 3-D computation model of the electrical activation in the heart and how it was influenced by adenosine and ablation. Find more images in the original article

News | Atrial Fibrillation | October 08, 2020
October 8, 2020 – People who suffer from persistent atrial fibrillation in the heart may find relief from a new treat